Role of fibre characteristics on cytotoxicity and induction of anaphase/telophase aberrations in rat pleural mesothelial cells in vitro: correlations with in vivo animal findings.
Thirteen samples of natural fibres and five samples of man-made fibres (MMF) were tested to determine their cytotoxicity and ability to produce chromosome missegregation in cultures in rat pleural mesothelial cells (RPMC). The natural samples included attapulgite, two amphiboles (amosite and crocidolite); seven consisted of chrysotile from various origins and three were obtained after chemical treatment of chrysotile. MMF included three refractory ceramic fibres (RCF) and two vitreous fibres (MMVF). All fibre samples were characterized by electron microscopic measurement of the fibre dimensions. Cytotoxicity was assayed on the basis of determination of mitochondrial integrity and chromosome missegregation by light microscopy examination of anaphases/telophases. The carcinogenic potency of 10 natural samples has been previously investigated using intrapleural inoculation in rats. It was therefore possible to establish correlations between in vitro and in vivo data obtained with the same set of samples. The various samples of chrysotile produced different in vitro effects, in agreement with the dispersion of response also observed in vivo. Cytotoxicity appears to be dependent on both fibre length and fibre diameter, as the longest or thickest fibres were the most toxic. The production of abnormal anaphases/telophases appears to depend on the presence of fibres of selected size, such as those previously defined by Stanton et al. (L > 8 micrograms; D < or = 0.25 microns); a threshold values was determined below which no abnormal anaphases/telophases were detected. This non-observable effect level was estimated to be 2.5 x 10(5) 'Stanton' fibres per cm2. There was no correlation between cytotoxicity and mesothelioma induction; in contrast, a correlation was found between the ability of a sample to produce chromosome missegregation in vitro and mesothelioma in vivo.
Yegles
M
M
INSERM U139, Institut Mondor de Médecine Moléculaire, IM3, Faculté de Médecine, Créteil, France.
Janson
X
X
Dong
H Y
HY
Renier
A
A
Jaurand
M C
MC
D000705:Anaphase; D000782:Aneuploidy; D000818:Animals; D001194:Asbestos / Q000633:toxicity*; D017639:Asbestos, Amosite / Q000633:toxicity; D017638:Asbestos, Crocidolite / Q000633:toxicity; D002470:Cell Survival; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D004848:Epithelium / Q000648:ultrastructure; D010994:Pleura / Q000648:ultrastructure*; D051381:Rats; D013692:Telophase
D017638:Asbestos, Crocidolite; D017639:Asbestos, Amosite; D001194:Asbestos